BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)
Status:
Withdrawn
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This is a pilot study examining biological endpoints in men with localized prostate cancer
who are scheduled to have radical prostatectomies and men with Benign Prostatic
Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS) following botulinum toxin type A (BoNT-A)
injection. Patients will serve as their own controls by receiving BoNT-A injections into the
right peripheral and transition zones and sham saline injections into the left peripheral and
transition zones.
Phase:
Early Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston